InsiderTrades

Form 4 for TCBI TEXAS CAPITAL BANCSHARES INC/TX

Accepted 2024-02-21 00:00:00 ET · period of report 2024-02-16 · accession 0001077428-24-000053 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-02-21 2024-02-16 TCBI Holmes Rob C Pres, CEO M - OptEx $0.00 +691 168.6K +0.4% $0
D 2024-02-21 2024-02-16 TCBI Holmes Rob C Pres, CEO F - Tax $59.55 -691 167.9K -0.4% -$41.1K
D 2024-02-21 2024-02-16 TCBI Holmes Rob C Pres, CEO M - OptEx $0.00 -691 58.1K -1% $0
D 2024-02-21 2024-02-16 TCBI Holmes Rob C Pres, CEO A - Grant $0.00 +58.8K 58.8K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-16 M A 691 $0.00 168,626 D — — (F1) The reported transaction involved the withholding of 691 shares of stock issuable upon the early vesting on an equal number of restricted stock units to pay taxes associated with the reporting person becoming retirement eligible.
2 Common Common Stock 2024-02-16 F D 691 $59.55 167,935 D — — (F1) The reported transaction involved the withholding of 691 shares of stock issuable upon the early vesting on an equal number of restricted stock units to pay taxes associated with the reporting person becoming retirement eligible.
3 Derivative 2024 Restricted Stock Units 2024-02-16 M D 691 $0.00 58,084 D $0.00 · 2025-02-16 to — 691 Common Stock (F1) The reported transaction involved the withholding of 691 shares of stock issuable upon the early vesting on an equal number of restricted stock units to pay taxes associated with the reporting person becoming retirement eligible. (F3) N/A
4 Derivative 2024 Restricted Stock Units 2024-02-16 A A 58,775 $0.00 58,775 D $0.00 · 2025-02-16 to — 58,775 Common Stock (F2) The restricted stock units vest in three equal annual installments beginning February 16, 2025.